Thursday, October 19, 2017 8:54:50 PM
Ludlow Research, a small cap equity research firm located in New York City, recently issued a note to their subscribers that investors wanting to invest in the marijuana sector may want to sell the growers, dispensaries, and recreational plays, and focus investment capital more in a diversified basket of companies focused strictly on the medical research side due to potential regulatory risks.
For this reason they have initiated coverage on IDVV based on their new management, low public float, and strict focus on non-psychoactive cannabis research for the treatment of a wide variety of illnesses, with a ‘speculative’ short-term target of around $2.00+ per share.
This would place IDVV with similar pure medical marijuana plays such as OWC Pharmaceutical Research Corp (OTC:OWCP) India Globalization Capital, Inc. (NYSE: IGC), Freedom Leaf, Inc. (OTC:FRLF), or Medical Marijuana Inc. (OTC:MJNA) to name a few.
http://www.wallstreetnewscast.com/idvv-1019/
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM